<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Over an 18-year period, 10 <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) patients with complex hyperdiploid karyotypes were identified </plain></SENT>
<SENT sid="1" pm="."><plain>According to the FAB classification, the 10 patients were subclassified as three <z:hpo ids='HP_0005505'>refractory anemias</z:hpo> (RA), three <z:hpo ids='HP_0005505'>refractory anemias</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), two <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t), and two unclassified <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>According to the WHO classification, the diagnoses were two RA, one refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, two <z:e sem="disease" ids="C1318550" disease_type="Neoplastic Process" abbrv="">RAEB-1</z:e>, one <z:e sem="disease" ids="C1318551" disease_type="Neoplastic Process" abbrv="">RAEB-2</z:e>, two unclassified <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and two <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Six were <z:e sem="disease" ids="C0280745" disease_type="Neoplastic Process" abbrv="">secondary MDS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Four patients showed marked dyserythropoiesis; three of these were <z:e sem="disease" ids="C0280745" disease_type="Neoplastic Process" abbrv="">secondary MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The chromosome number ranged from 47 to 62, and <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e> or composite karyotypes were noted in 7 patients </plain></SENT>
<SENT sid="6" pm="."><plain>Seven patients had at least one clone with &gt;50 chromosomes </plain></SENT>
<SENT sid="7" pm="."><plain>Recurrent defects included chromosome 5, 17, and 13 abnormalities </plain></SENT>
<SENT sid="8" pm="."><plain>Notably, <z:mp ids='MP_0004027'>trisomy</z:mp> 8 and <z:mp ids='MP_0004026'>monosomy</z:mp> 7 were rare in that group of patients </plain></SENT>
<SENT sid="9" pm="."><plain>Three of four patients with marked dyserythropoiesis shared abnormalities of both chromosomes 13 and 17 </plain></SENT>
</text></document>